As of Jan 19
| 0.00 / 0.00%|
The 21 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 64.00, with a high estimate of 75.00 and a low estimate of 49.00. The median estimate represents a +2.76% increase from the last price of 62.28.
The current consensus among 24 polled investment analysts is to Hold stock in Bristol-Myers Squibb Co. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.